Evidence map›Paper›PMID 29084996›Full record

ArticleScientific reports2017

Host genotype and time dependent antigen presentation of viral peptides: predictions from theory.

R Charlotte Eccleston, Peter V Coveney, Neil Dalchau

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. When we can trust computers (and when we can't).Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2021
    Article
  3. Article
  4. The influence of HLA/HIV genetics on the occurrence of elite controllers and a need for therapeutics geotargeting view.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

R Charlotte EcclestonCentre for Computational Science, Department of Chemistry, University College London, London, WC1H 0AJ, UK.
Peter V CoveneyCentre for Computational Science, Department of Chemistry, University College London, London, WC1H 0AJ, UK.ORCID 0000-0002-8787-7256
Neil DalchauMicrosoft Research, Cambridge, CB1 2FB, UK. ndalchau@microsoft.com.ORCID 0000-0002-4872-6914
University College London · GBMicrosoft Research (United Kingdom) · GB

Funding

Medical Research Council MR/L016311/1
6 · The paper itself

Abstract

The rate of progression of HIV infected individuals to AIDS is known to vary with the genotype of the host, and is linked to their allele of human leukocyte antigen (HLA) proteins, which present protein degradation products at the cell surface to circulating T-cells. HLA alleles are associated with Gag-specific T-cell responses that are protective against progression of the disease. While Pol is the most conserved HIV sequence, its association with immune control is not as strong. To gain a more thorough quantitative understanding of the factors that contribute to immunodominance, we have constructed a model of the recognition of HIV infection by the MHC class I pathway. Our model predicts surface presentation of HIV peptides over time, demonstrates the importance of viral protein kinetics, and provides evidence of the importance of Gag peptides in the long-term control of HIV infection. Furthermore, short-term dynamics are also predicted, with simulation of virion-derived peptides suggesting that efficient processing of Gag can lead to a 50% probability of presentation within 3 hours post-infection, as observed experimentally. In conjunction with epitope prediction algorithms, this modelling approach could be used to refine experimental targets for potential T-cell vaccines, both for HIV and other viruses.

Indexed as

AlgorithmsAntigen PresentationCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesComputer SimulationEpitopesEpitopes, T-LymphocyteForecastinggag Gene Products, Human Immunodeficiency VirusGene Products, gagGenes, MHC Class IGenotypeHistocompatibility Antigens Class IIHIV-1HIV AntigensHIV InfectionsEpitopesEpitopes, T-Lymphocytegag Gene Products, Human Immunodeficiency VirusGene Products, gagHistocompatibility Antigens Class IIHIV AntigensImmunodominant EpitopesPeptides

Identifiers

PMID29084996
PMCPMC5662608
OpenAlexW2766125441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.